Beta Bionics

About:

Beta Bionics is a biotechnology company that develops an integrated bionic pancreas system called the iLet.

Website: http://www.betabionics.com

Twitter/X: betabionics

Top Investors: Eli Lilly, Wellington Management, Perceptive Advisors, Marshall Wace, Dexcom

Description:

Beta Bionics is a biotechnology company that develops an integrated bionic pancreas system called the iLet. The iLet Bionic Pancreas System was granted breakthrough designation in all configurations (insulin-only, glucagon-only, and bihormonal), including use with Zealand Pharma’s dasiglucagon, a glucagon analogue with a stability profile in a ready-to-use aqueous solution. It also offers a bionic pancreas device for glucose metabolism to the diabetes community.

Total Funding Amount:

$353M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Irvine, California, United States

Founded Date:

2015-10-21

Contact Email:

admin(AT)betabionics.org

Founders:

Ed Damiano, Sean Saint, Toby Milgrome

Number of Employees:

101-250

Last Funding Date:

2024-11-13

IPO Status:

Private

© 2025 bioDAO.ai